Literature DB >> 21867584

Endoscopic devascularisation of sphenopalatine bundle in intractable posterior epistaxis: technique, efficacy and safety.

H M Eladl1, S M Elmorsy, Y W Khafagy.   

Abstract

OBJECTIVE: To evaluate endoscopic cauterisation of the sphenopalatine neurovascular bundle, as treatment for intractable posterior epistaxis, with regard to efficacy, safety and post-operative sequelae. PATIENTS AND METHODS: A prospective study reviewed 42 patients with severe posterior epistaxis who were treated with endoscopic cauterisation of the sphenopalatine neurovascular bundle, over a 17-month period.
RESULTS: Hypertension and hepatic disease were present as predisposing factors in 66.7 and 35.7 per cent of patients, respectively. Branching of the sphenopalatine artery at its foramen was present in more than 85 per cent of patients. The success rate was 100 per cent, with no recurrent epistaxis in the follow-up period. Severe nasal dryness was present in only four patients (9.5 per cent); hypoaesthesia was found in the nasal mucosa of eight patients, without any patient complaints.
CONCLUSION: Endoscopic sphenopalatine neurovascular bundle cauterisation is an effective treatment for refractory posterior epistaxis. In this study, neurovascular bundle cauterisation did not cause any neurological deficits or major complications.

Entities:  

Mesh:

Year:  2011        PMID: 21867584     DOI: 10.1017/S0022215111002180

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Treatment of sphenopalatine artery bleeding.

Authors:  Zhengcai Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-09       Impact factor: 2.503

3.  A blind area of origins of epistaxis: technical or cognitive?

Authors:  Wei Wei; Yuting Lai; Chaoping Zang; Jiqin Luo; Bijun Zhu; Quan Liu; Ying Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-24       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.